These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 27653615

  • 1. Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
    Beyer LP, Pregler B, Michalik K, Niessen C, Dollinger M, Müller M, Schlitt HJ, Stroszczynski C, Wiggermann P.
    Int J Comput Assist Radiol Surg; 2017 May; 12(5):803-809. PubMed ID: 27653615
    [Abstract] [Full Text] [Related]

  • 2. Robot-assisted microwave thermoablation of liver tumors: a single-center experience.
    Beyer LP, Pregler B, Niessen C, Dollinger M, Graf BM, Müller M, Schlitt HJ, Stroszczynski C, Wiggermann P.
    Int J Comput Assist Radiol Surg; 2016 Feb; 11(2):253-9. PubMed ID: 26307269
    [Abstract] [Full Text] [Related]

  • 3. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P, Nilsson A, Duraj F, Haglund U, Norén A.
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [Abstract] [Full Text] [Related]

  • 4. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung EM, Zeman F, Stroszczynski C, Wiggermann P.
    Diagn Interv Radiol; 2015 Apr; 21(6):471-5. PubMed ID: 26359870
    [Abstract] [Full Text] [Related]

  • 5. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M, Müller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.
    PLoS One; 2015 Apr; 10(8):e0135773. PubMed ID: 26270651
    [Abstract] [Full Text] [Related]

  • 6. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, Izzo F, Gallipoli AD, Petrillo A.
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [Abstract] [Full Text] [Related]

  • 7. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ, Vroomen LG, Nielsen K, van Tilborg AA, Comans EF, van Kuijk C, van der Meijs BB, van den Bergh J, van den Tol PM, Meijerink MR.
    BMC Cancer; 2015 Oct 24; 15():772. PubMed ID: 26497813
    [Abstract] [Full Text] [Related]

  • 8. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, Kuhl CK, Bruners P.
    Radiology; 2017 Dec 24; 285(3):1023-1031. PubMed ID: 28799842
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
    Bhutiani N, Philips P, Scoggins CR, McMasters KM, Potts MH, Martin RC.
    HPB (Oxford); 2016 Jul 24; 18(7):593-9. PubMed ID: 27346140
    [Abstract] [Full Text] [Related]

  • 10. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
    Sugimoto K, Moriyasu F, Kobayashi Y, Saito K, Takeuchi H, Ogawa S, Ando M, Sano T, Mori T, Furuichi Y, Nakamura I.
    Jpn J Radiol; 2015 Jul 24; 33(7):424-32. PubMed ID: 26032929
    [Abstract] [Full Text] [Related]

  • 11. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z, Lu J, Huang W, Wu Z, Gong J, Wang Q, Liu Q, Wang C, Zhu Y, Ding X, Wang Z.
    BMC Cancer; 2021 Feb 05; 21(1):124. PubMed ID: 33546635
    [Abstract] [Full Text] [Related]

  • 12. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
    Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Müller-Wille R, Stroszczynski C, Wiggermann P.
    J Vasc Interv Radiol; 2014 Oct 05; 25(10):1589-94. PubMed ID: 25156648
    [Abstract] [Full Text] [Related]

  • 13. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ, Pech M, Fischbach F, Jürgens J, Friebe B, Baumunk D, Porsch M, Blaschke S, Schindele D, Siedentopf S, Ricke J, Schostak M, Köllermann J, Liehr UB.
    Urology; 2018 Apr 05; 114():224-232. PubMed ID: 29305201
    [Abstract] [Full Text] [Related]

  • 14. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A, Amendola F, Calvanese A, Ingenito E, Santoro B, Gatti P, Ciracì E, Matteucci P, Giorgio V.
    J Ultrasound; 2019 Mar 05; 22(1):53-58. PubMed ID: 30843171
    [Abstract] [Full Text] [Related]

  • 15. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP.
    Arch Surg; 2012 Nov 05; 147(11):1053-61. PubMed ID: 23165618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
    Sugimoto K, Moriyasu F, Saito K, Kobayashi Y, Itoi T.
    J Med Ultrason (2001); 2017 Jul 05; 44(3):247-254. PubMed ID: 27933441
    [Abstract] [Full Text] [Related]

  • 18. Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial.
    Beyer LP, Pregler B, Nießen C, Schicho A, Haimerl M, Jung EM, Stroszczynski C, Wiggermann P.
    PeerJ; 2016 Jul 05; 4():e2277. PubMed ID: 27602266
    [Abstract] [Full Text] [Related]

  • 19. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
    Rennert J, Wiesinger I, Schicho A, Wiggermann P, Stroszczynski C, Beyer LP, Jung EM.
    J Gastrointestin Liver Dis; 2019 Sep 01; 28(3):311-318. PubMed ID: 31517328
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.